Search | Page 6 | ASTRO

Science Highlights 2024: Breast Cancer
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy
Radiopharmaceutical Therapy Workshop 2024
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC): Race-GB Study
2025 ASTRO Annual Refresher Course onDemand
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
eContouring for Primary Hepatobiliary Tumors
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?
Moving Beyond Auditory Speech: Improving Equity for Patients and Providers with Diverse Communication Needs
What I Wish I Knew in the Early Career Period
eContouring for Head and Neck Cancer - Tongue - Case Library
Stereotactic Body Radiation Therapy for Primary Lung Cancer and Metastases: A Case Based Discussion on Challenging Cases
How to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
Radiotherapy for Meningiomas – Where Do We Stand and What’s on the Horizon?
Moving from the Background Towards the Spotlight: A Critical Review of Radiation Therapy for Locally Advanced Pancreas Cancer
Gray Zone - Which Way to (INDI)GO?
The Evolution of Cancer Within a Patient: Tumor Phylogenetics and Implications for Local Therapy
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting
Gynecologic Tumor Board–Case-Based Discussion of the Molecular & Treatment Approach Updates for the Management of Endometrial, Vulvar & Cervical Cancers
Salvage Therapy for Local-Regional Breast Cancer Recurrence: What, When, and How Much?
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
eContouring for Gynecologic Cancers Webinar

Pages